Korean Market
EXCH
Access Bio
★★

Acquisition of 80.24% Stake in RF Bio for 57B KRW, Entering Medical Aesthetics & Biotech

 
PERI
Access Bio
★★

Access Bio: Continued Losses Due to COVID-19 Sales Plunge, Self-Share Cancellation and Business Diversification

 
EXCH
Access Bio
★★★★

Correction of Treasury Stock Cancellation Decision (Date Change and AGM Approval)